Upload Image (Max 20MB per Image)
Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60m, with future contingent consideration based on the ...
Tags: Takeda, LigoCyte Pharmaceuticals, Norovirus vaccine